Response.
Toronto, Ont.
Gideon
G
Koren
D002047:Buprenorphine / Q000009:adverse effects*; D005260:Female; D006801:Humans; D009270:Naloxone / Q000009:adverse effects*; D009292:Narcotic Antagonists / Q000009:adverse effects*; D009293:Opioid-Related Disorders / Q000188:drug therapy*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*
D009292:Narcotic Antagonists; D009270:Naloxone; D002047:Buprenorphine